At Reviva we are focused on developing a drug that targets both the serotonin and dopamine receptor signaling systems to more effectively treat schizophrenia and its comorbid symptoms.” ...
Study author Alison G. P. Wakeford and colleagues aimed to explore the effects of childhood maltreatment on serotonin receptors (5HT1A and 5HT2A) and dopamine (D2) receptors in the brain.
post-synaptic neuronal receptors—a serotonin receptor subtype—in the brain via RNA or DNA genetic edits. The company’s current focus is on treating MCI and chronic anxiety, to meet the needs ...
noradrenergic and specific serotonin receptor antagonists, dopamine and norepinephrine reuptake inhibitors, along with newly introduced antidepressants (e.g., vilazodone and agomelatine).
Serotonin (5-hydroxytryptamine [5-HT]) receptor subtypes, such as the 5-HT 1A receptor, are considered to mediate the ability of antipsychotic drugs to enhance cognition. On the other hand ...
This finding led to the development of drugs that interact with serotonin or its receptors to regulate food consumption and ...